Holen Sie sich die Stockscreener-App
0.1334
24.51%
-0.1779
Schlusskurs vom Vortag:
$0.3113
Offen:
$0.135986
24-Stunden-Volumen:
30,675
Relative Volume:
66.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.29M
KGV:
-0.0369
EPS:
-3.62
Netto-Cashflow:
$-5.16M
1W Leistung:
-24.51%
1M Leistung:
-62.29%
6M Leistung:
-84.44%
1J Leistung:
-93.80%
1-Tages-Spanne:
$0.1333
$0.1408
1-Wochen-Bereich:
$0.1333
$0.1408
52-Wochen-Spanne:
$0.1333
$0.1408
Zyversa Therapeutics Inc Stock (ZVSA) Company Profile
Firmenname
Zyversa Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ZVSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZVSA
Zyversa Therapeutics Inc
|
0.1334 | 0 | 0 | -8.29M | -5.16M | -3.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Zyversa Therapeutics Inc Aktie (ZVSA) Neueste Nachrichten
Investment Report: How risky is ZyVersa Therapeutics Inc stock nowWeekly Market Report & Daily Momentum Trading Reports - moha.gov.vn
Is ZyVersa Therapeutics Inc. stock a buy for dividend growthDollar Strength & Fast Entry High Yield Stock Tips - Newser
[8-K] ZyVersa Therapeutics, Inc. Reports Material Event | ZVSA SEC FilingForm 8-K - Stock Titan
ZyVersa Therapeutics Delays 10-Q Filing - MSN
Is ZyVersa Therapeutics Inc. stock safe for conservative investorsTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
Zyversa Therapeutics Faces Financial Challenges Amid Drug Development - TipRanks
What institutional flow reveals about ZyVersa Therapeutics Inc.Trade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
A activityEntry Point & AI Powered Buy/Sell Recommendations - newser.com
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results - The Manila Times
[10-Q] ZyVersa Therapeutics, Inc. Quarterly Earnings Report | ZVSA SEC FilingForm 10-Q - Stock Titan
ZyVersa Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
ZyVersa Therapeutics Inc. stock volume spike explainedPrice Action & Free Technical Confirmation Trade Alerts - newser.com
What makes ZyVersa Therapeutics Inc. stock attractive to growth fundsJuly 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
Can ZyVersa Therapeutics Inc. stock hit record highs again2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com
Zyversa Therapeutics’ Promising Phase 2a Study on DKD Treatment - MSN
ZyVersa Therapeutics Inc. (ZVSA) Stock Price | Live Quotes & Charts | OTCQB - StocksToTrade
Can ZyVersa Therapeutics Inc. stock maintain operating marginsRate Hike & Low Drawdown Investment Strategies - newser.com
Can ZyVersa Therapeutics Inc. recover in the next quarterEntry Point & High Accuracy Trade Signal Alerts - newser.com
Analyzing ZyVersa Therapeutics Inc. with risk reward ratio charts2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Trio Petroleum Corp. Common Stock (NY: TPET - Markets Financial Content
[NT 10-Q] ZyVersa Therapeutics, Inc. SEC Filing - Stock Titan
Is ZyVersa Therapeutics Inc. reversing from oversold territoryMarket Volume Summary & Entry and Exit Point Strategies - newser.com
Will ZyVersa Therapeutics Inc. stock gain from lower inflationWeekly Trend Report & Safe Capital Growth Plans - newser.com
Relative strength of ZyVersa Therapeutics Inc. in sector analysisSell Signal & Technical Analysis for Trade Confirmation - newser.com
ZyVersa Therapeutics' CEO, Stephen C. Glover, Is Invited Speaker at BioFlorida 2022 Annual Conference - GuruFocus
Finanzdaten der Zyversa Therapeutics Inc-Aktie (ZVSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
Kapitalisierung:
|
Volumen (24h):